Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye-Xuan Cao

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Cardiovascular Medicine|March 14, 2022
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial InfarctionYe-Xuan Cao, Sha Li, Hui-Hui Liu, et al.
Coronary Artery Disease|August 18, 2020
Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patientsYan-Pu Shi, Ye-Xuan Cao, Jing-Lu Jin, et al.
Journal of the American Heart Association|January 28, 2021
Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary InterventionHui-Hui Liu, Ye-Xuan Cao, Jing-Lu Jin, et al.
Cardiovascular Diabetology|April 23, 2021
Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort studyHui-Hui Liu, Ye-Xuan Cao, Jing-Lu Jin, et al.
Journal of Translational Medicine|November 13, 2019
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapyYe-Xuan Cao, Jing-Lu Jin, Di Sun, et al.
Lipids in Health and Disease|January 8, 2022
NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort studyJia Peng, Ming-Ming Liu, Jing-Lu Jin, et al.
Annals of Vascular Surgery|January 2, 2026
Impact of pitavastatin on carotid plaque regression in patients with hypercholesterolemiaYe-Xuan Cao, Chun-Lin Yin, Chun-Fei Zhang, et al.
Cardiovascular Diabetology|October 7, 2020
Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort studyJia Peng, Ming-Ming Liu, Jing-Lu Jin, et al.
Personalized Medicine|November 7, 2019
Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemiaYe-Xuan Cao, Bing-Yang Zhou, Di Sun, et al.
Hepatology International|October 9, 2021
Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case-control studyHui-Hui Liu, Ye-Xuan Cao, Jing-Lu Jin, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Cardiovascular Medicine|March 14, 2022
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial InfarctionYe-Xuan Cao, Sha Li, Hui-Hui Liu, et al.
Coronary Artery Disease|August 18, 2020
Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patientsYan-Pu Shi, Ye-Xuan Cao, Jing-Lu Jin, et al.
Journal of the American Heart Association|January 28, 2021
Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary InterventionHui-Hui Liu, Ye-Xuan Cao, Jing-Lu Jin, et al.
Cardiovascular Diabetology|April 23, 2021
Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort studyHui-Hui Liu, Ye-Xuan Cao, Jing-Lu Jin, et al.
Journal of Translational Medicine|November 13, 2019
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapyYe-Xuan Cao, Jing-Lu Jin, Di Sun, et al.
Lipids in Health and Disease|January 8, 2022
NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort studyJia Peng, Ming-Ming Liu, Jing-Lu Jin, et al.
Annals of Vascular Surgery|January 2, 2026
Impact of pitavastatin on carotid plaque regression in patients with hypercholesterolemiaYe-Xuan Cao, Chun-Lin Yin, Chun-Fei Zhang, et al.
Cardiovascular Diabetology|October 7, 2020
Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort studyJia Peng, Ming-Ming Liu, Jing-Lu Jin, et al.
Personalized Medicine|November 7, 2019
Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemiaYe-Xuan Cao, Bing-Yang Zhou, Di Sun, et al.
Hepatology International|October 9, 2021
Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case-control studyHui-Hui Liu, Ye-Xuan Cao, Jing-Lu Jin, et al.
Pageof 6